Merck
CN
Search Within
文件类型

213-332-8

应用筛选条件
关键词:'213-332-8'
显示 1-19 共 19 条结果 关于 "213-332-8" 范围 技术文档
Product Information Sheet - 11442066001
ready-to-use tablets 20 tablets 11 697 471 001 NBT/BCIP Stock Solution 8 ml 11 681 451 001 NBT Solution 3 ml (300 mg) 11 383 213 001 NBT crystals 5 g 11 585 029 001 Labeling of Biomolecules
XP725 Antibody Number-Lot Number 071M4826
.4 301 302 303 304 325 326 327 328 349 350 351 352 373 374 375 376 4.5 305 306 307 308 329 330 331 332 353 354 355 356 377 378 379 380 4.64. 309 310 311 312 333 334 335
Product Information Sheet-11383221001
Conjugate, 500 U 11 089 153 001 Tween 20 50 ml, 5 x 10 ml 11 332 465 001 4-Nitro blue tetrazolium chloride (NBT) 3 ml, 300 mg 11 383 213 001 DIG Wash and Block Buffer Set 1 set, 30 blots
Product Information Sheet-11383213001
11 112 481 001 Streptavidin-POD Conjugate, 500 U 11 089 153 001 Tween 20 50 ml, 5 x 10 ml 11 332 465 001 BCIP 3 ml, 150 mg 11 383 221 001 250 mg 10 760 994 001 1 g 11
Product Information Sheet - 11383213001
ready-to-use Tablets 20 tablets 11 697 471 001 Streptavidin-AP 150 U 11 093 266 910 Tween 20 5x 10 ml 11 332 465 001 http://www.sigmaaldrich.com/technical-service-home.html http://www.sigmaaldrich.com
Corticotropin-Releasing Factor Receptor Antagonists- Potential Novel Therapies for Human Disease
-456 (2000). 89. Gilligan, P.J., et al., Bioorg. Med. Chem., 8, 181-189 (2000). 90. Gully, D., et al., J. Pharmacol. Exp. Ther., 301, 322-332 (2002). 91. Okuyama, S., et al., J. Pharmacol. Exp. Ther., 289
XP725 Antibody List Lot 129K4831
28 AP Endonuclease A2105 328 APEX1 M NP_001632.2,NP_542379.1,NP_542380.1 y y y 692 Survivin S8191 332 BIRC5 P NP_001012270.1 y y y 17 β-Amyloid A8354 351 APP M NP_000475.1,NP_001129488.1 ,NP_001129601.1
XP725 Antibody List Lot 129K4830
28 AP Endonuclease A2105 328 APEX1 M NP_001632.2,NP_542379.1,NP_542380.1 y y y 692 Survivin S8191 332 BIRC5 P NP_001012270.1 y y y 17 β-Amyloid A8354 351 APP M NP_000475.1,NP_001129488.1 ,NP_001129601.1
XP725 Antibody List Lot 089K4791
28 AP Endonuclease A2105 328 APEX1 M NP_001632.2,NP_542379.1,NP_542380.1 y y y 692 Survivin S8191 332 BIRC5 P NP_001012270.1 y y y 17 β-Amyloid A8354 351 APP M NP_000475.1,NP_001129488.1 ,NP_001129601.1
Panorama Human Protein Functional Array-Signal Transduction
baculoviral IAP repeat-containing protein 3 330 BIRC5 baculoviral IAP repeat-containing 5 (survivin) 332 BLK B lymphoid tyrosine kinase 640 BMP7 bone morphogenetic protein 7 (osteogenic protein 1) 655
XP725 Antibody List
y 331 HDAC-5 H8163 84580, 10014, 15184 Hdac5,HDAC5 XP_001081495.1,NP_005465.2,NP_034542.3 P y y y 332 HDAC-6 H2287 15185, 10013 HDAC6,Hdac6 NP_034543.2,NP_006035.2 P y y n/d 333 HDAC-7 H2537 84582, 56233
XP725 Antibody List 013M4793
y 331 HDAC-5 H8163 84580, 10014, 15184 Hdac5,HDAC5 XP_001081495.1,NP_005465.2,NP_034542.3 P y y y 332 HDAC-6 H2287 15185, 10013 HDAC6,Hdac6 NP_034543.2,NP_006035.2 P y y n/d 333 HDAC-7 H2537 84582, 56233
XP725 Worksheet for Lot Number 071M4826
326 2 3 5 6 Centrin C7736 327 2 3 5 7 Chk1 C9358 328 2 3 5 8 Chk1 C9358 329 2 3 6 1 Chk2 C9108 330 2 3 6 2 Chk2 C9108 331 2 3 6 3 Chk2 C9233 332 2 3 6
List of Antibodies
Control NA 330 HDAC-5 H4538 M y y y 331 HDAC-5 H8163 P y y y 332 HDAC-6 H2287 P y y n/d 333 HDAC-7 H2537 P y y y 334 HDAC-7 H6663 M y y n/d 335 HDAC-8 H6412 M y n/d n/d 336 Anti Cy3+Cy5
3D BIOPRINTING: Printing a Brighter Future
Vijayavenkataraman, S.; Yan, W.-C.; Lu, W. F.; Wang, C.-H.; Fuh, J. Y. H. Adv. Drug Deliv. Rev. 2018, 132, 296–332. (5) Fonseca, A. C.; Melchels, F. P. W.; Ferreira, M. J. S.; Moxon, S. R.; Potjewyd, G.; Dargaville
3D BIOPRINTING: Printing a Brighter Future
Vijayavenkataraman, S.; Yan, W.-C.; Lu, W. F.; Wang, C.-H.; Fuh, J. Y. H. Adv. Drug Deliv. Rev. 2018, 132, 296–332. (5) Fonseca, A. C.; Melchels, F. P. W.; Ferreira, M. J. S.; Moxon, S. R.; Potjewyd, G.; Dargaville
Brochure: Chromolith® Monolithic Silica HPLC Columns for small and large molecule separation
buffer, pH 3.0 Gradient with flow gradient: Initial composition: 0 – 8 min 55% A 45% B isocratic, flow increases from 213 μL/min to 425 μL/min, 8.1 – 20 min 65% A 35% B isocratic, flow 850 μL/min
Halal Certificate
330. ACETOVANILLONE W508454 C44278 HC-23SILC11 331. Alginic Acid W800014 B95987 HC-23SIMI37 332. Allyl Butyrate W202118 C32914 HC-23SI6N49 333. ALLYL CYCLOHEXANEPROPIONATE 98%, FCC, FG W202606
Halal Certificate
330. ACETOVANILLONE W508454 C44278 HC-22SI3Y32 331. Alginic Acid W800014 B95987 HC-22SIZL58 332. Allyl Butyrate W202118 C32914 HC-22SIHX70 333. ALLYL CYCLOHEXANEPROPIONATE 98%, FCC, FG W202606